Dennis Purcell, founder and senior advisor of Aisling Capital. See contact routes.
Dennis Purcell, founder and senior advisor of Aisling Capital, invests primarily in early-stage biopharmaceutical and life science companies, focusing on sectors like genomically defined cancers, therapeutics, and clinical outsourcing services. His firm’s distinctive thesis requires clinical trial data, reasonable valuations, and a 3–5-year exit horizon before entering a deal. Notable portfolio companies include Adams Respiratory Therapeutics, which Purcell helped take public and later achieved an 8–9x return, and approximately two dozen other life sciences firms backed through the Perseus-Soros BioPharmaceutical Fund.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in New York.
Investors like Dennis Purcell · Full investor directory · Investor access · Company funding database